Home › Funds › ADAR1 Capital Management, LLC › ZURA
ADAR1 Capital Management, LLC position in ZURA
ZURA BIO · Health Care
ADAR1 Capital Management, LLC reported holding 1,759,295 shares of ZURA (ZURA BIO) in its Q2 2026 13F filing — a position valued at US$10.4M, representing 0.57% of its reported portfolio and ranking #48 among its reported holdings. ADAR1 Capital Management, LLC has disclosed ZURA holdings in 8 of the last 8 reported quarters, going back to Q3 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How ADAR1 Capital Management, LLC's ZURA position evolved
ADAR1 Capital Management, LLC first disclosed a stake in ZURA in Q3 2024 at 3,770,649 shares (US$15.3M). Across 8 filings, ADAR1 Capital Management, LLC increased the stake 3 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,759,295 shares valued at US$10.4M — an increase of 1,128,892 shares quarter over quarter.. Notable position changes include a 45% trim in Q4 2024 (shares fell 48% over the following quarter), a 64% trim in Q2 2025 (shares rose 312% over the following quarter), a 179% increase in Q2 2026 (shares fell 29% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 3.77M | $15.31M | New |
| Q4 2024 | 2.08M | $5.19M | Reduce |
| Q1 2025 | 2.80M | $3.61M | Add |
| Q2 2025 | 997.55K | $1.05M | Reduce |
| Q3 2025 | 652.15K | $2.82M | Reduce |
| Q4 2025 | 562.07K | $2.95M | Reduce |
| Q1 2026 | 630.40K | $3.75M | Add |
| Q2 2026 | 1.76M | $10.38M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ZURA and 13F data
ZURA (ZURA BIO) is a Health Care company. 52 other funds we track also report a position in ZURA — the largest reported positions include MONTANOVA CAPITAL, LLC (US$55.7M), Venrock Adviser, LLC (US$38.0M), MPM BioImpact LLC (US$26.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ZURA
- MONTANOVA CAPITAL, LLC 9.44M sh · $55.71M · Q2 2026
- Venrock Adviser, LLC 6.43M sh · $37.97M · Q2 2026
- MPM BioImpact LLC 4.47M sh · $26.39M · Q2 2026
- GREAT POINT PARTNERS LLC 4.22M sh · $24.87M · Q2 2026
- BRAIDWELL LP 3.98M sh · $23.48M · Q2 2026
- Commodore Capital LP 3.25M sh · $19.18M · Q2 2026
- Saturn V Capital Management LP 2.10M sh · $12.40M · Q2 2026
- QVT Financial LP 1.90M sh · $11.18M · Q2 2026
- STEMPOINT CAPITAL LP 1.37M sh · $8.07M · Q2 2026
- Ikarian Capital, LLC 1.22M sh · $7.19M · Q2 2026
- EcoR1 Capital, LLC 1.18M sh · $6.96M · Q2 2026
- Boxer Capital Management, LLC 900.00K sh · $5.31M · Q2 2026
More on ADAR1 Capital Management, LLC
FAQ
How long has ADAR1 Capital Management, LLC held ZURA?
ADAR1 Capital Management, LLC has disclosed ZURA holdings in 8 of the last 8 reported quarters, going back to Q3 2024.
What is ADAR1 Capital Management, LLC's current position in ZURA?
As of Q2 2026, ADAR1 Capital Management, LLC holds 1.76M shares of ZURA (ZURA BIO), valued at $10.38M, representing 0.57% of its reported portfolio and ranking #48.
Has ADAR1 Capital Management, LLC been buying or selling ZURA?
In the latest 13F filing (Q2 2026), ADAR1 Capital Management, LLC increased its position in ZURA.
Which other funds hold ZURA?
Other major institutional holders of ZURA include MONTANOVA CAPITAL, LLC, Venrock Adviser, LLC, MPM BioImpact LLC, among 52 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.